Rin Institute Inc.
Records under this name other than the patents Rin Institute Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 4 of 4 · Back to Rin Institute Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,192,956 | Antibody Binding to TMEM132A, Anticancer Agent, and Cancer Test Method Formerly held In force · High confidence | In force | High confidence | |
| US 12,509,507 | Fusion Protein Suitable for Dissolving Fibrin Clot, and Pharmaceutical Composition Containing Said Fusion Protein Formerly held In force · High confidence | In force | High confidence | |
| US 11,377,504 | Antibody Beneficial for Treatment of Solid Tumors, Antibody-Drug Conjugate, and Cancer Drug Including Same Lapsed on the fee record Ended Jul 5, 2026 · High confidence | Lapsed on the fee record | Ended Jul 5, 2026 | High confidence |
| US 11,311,626 | Plasmin-cleavable anti-insoluble fibrin antibody-drug conjugate Lapsed on the fee record Ended Apr 26, 2026 · USPTO record | Lapsed on the fee record | Ended Apr 26, 2026 | USPTO record |